Exercise of Share Options and Total Voting Rights | Company Announcement investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
On March 7, Celadon Pharmaceuticals plc, a leading UK-based pharmaceutical company specializing in cannabis-based medicines, unveiled promising findings from an early economic analysis of its chronic pain clinical trial, dubbed CANPAIN.
Celadon Pharmaceuticals (LON:CEL – Free Report) had its price objective upped by Canaccord Genuity Group from GBX 210 ($2.56) to GBX 235 ($2.87) in a research report report published on Friday morning, MarketBeat reports. They currently have a speculative buy rating on the stock. Separately, Canaccord Genuity Group reaffirmed a speculative buy rating and set […]
Celadon Pharmaceuticals plc (“Celadon” or the “Company” or the “Group”) Unaudited Interim results for the six months ended 30 June 2023 London, 28 September 2023 – Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the develo.